Takuya Ogami

Takuya Ogami

Auto-generated profile, based on publicly available information

Takuya Ogami

UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TOTakuya Ogami
Takuya Ogami
PKPaul Kurlansky
Paul Kurlansky
HTHiroo Takayama
Hiroo Takayama
YNYuming Ning
Yuming Ning
ZAZiad Ali
Ziad Ali
IGIsaac George
Isaac George
Background: Aortic stenosis is prevalent in end‐stage renal disease. Transcatheter aortic valve replacement (TAVR) is a plausible alternative for surgical aortic valve replacement. However, little is known regarding long‐term outcomes in patients with end‐stage renal disease who undergo TAVR. Methods and Results: We identified all patients with end‐stage renal disease who underwent TAVR from 2011 through 2016 using the United States Renal Data System. The primary end point was 5‐year mortality after TAVR. Factors associated with 1‐ and 5‐year mortality were analyzed. A total of 3883 TAVRs were performed for patients with end‐stage renal disease. Mortality was 5.8%, 43.7%, and 88.8% at 30 days, 1 year, and 5 years, respectively. Case volumes increased rapidly from 17 in 2011 to 1495 in 2016. Thirty‐day mortality demonstrated a dramatic reduction from 11.1% in 2012 to 2.5% in 2016 ( P =0.01). Age 75 or older (hazard ratio [HR], 1.14; 95% CI, 1.05–1.23 [ P =0.002]), body mass index <25 (HR, 1.18; 95% CI, 1.08–1.28 [ P <0.001]), chronic obstructive pulmonary disease (HR, 1.25; 95% CI, 1.1–1.35 [ P <0.001]), diabetes mellitus as the cause of dialysis (HR, 1.22; 95% CI, 1.11–1.35 [ P <0.001]), hypertension as the cause of dialysis (HR, 1.17; 95% CI, 1.06–1.29 [ P =0.004]), and White race (HR, 1.17; 95% CI, 1.06–1.3 [ P =0.002]) were independently associated with 5‐year mortality. Conclusions: Short‐term outcomes of TAVR in patients with end‐stage renal disease have improved significantly. However, long‐term mortality of patients on dialysis remains high.

15 June 2023 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
TOTakuya Ogami
Takuya Ogami
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
HPHimanshu J. Patel
Himanshu J. Patel
CPChih-Wen Pai
Chih-Wen Pai
KEKim A. Eagle
Kim A. Eagle
ISIbrahim Sultan
Ibrahim Sultan

7 March 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
SYSarah Yousef
Sarah Yousef
JBJames A. Brown
James A. Brown
EAEdgar Aranda-Michel
Edgar Aranda-Michel
DSDerek Serna‐Gallegos
Derek Serna‐Gallegos
YWYisi Wang
Yisi Wang
ISIbrahim Sultan
Ibrahim Sultan
Background: Thoracic endovascular aortic repair (TEVAR) has been increasingly used for the treatment of descending thoracic aortic aneurysms and dissections. This study sought to evaluate the influence of sex on outcomes after TEVAR. Methods and Results: This was an observational study from the Nationwide Readmissions Database analyzing all patients who underwent TEVAR from 2010 to 2018. Sampling weights were used to generate national estimates. International Classification of Diseases–Clinical Modification codes were used to identify patients with thoracic aortic aneurysms or dissections who underwent TEVAR. Patients were dichotomized according to sex, and 1:1 propensity score matching was applied. Mixed model regression for in‐hospital mortality and weighted logistic regression with bootstrapping for 30‐day readmissions were performed. A supplemental analysis was performed according to pathology (aneurysm or dissection). A weighted total of 27 118 patients were identified. Propensity‐matching yielded 5026 risk‐adjusted pairs. Men were more likely to undergo TEVAR for type B aortic dissection, whereas women were more likely to undergo TEVAR for aneurysm. In‐hospital mortality was roughly 5% and was equivalent in the matched groups. Men were more likely to have paraplegia, acute kidney injury, and arrhythmias, while women were more likely to require transfusions after TEVAR. There were no significant differences in myocardial infarction, heart failure, respiratory failure, spinal cord ischemia, mesenteric ischemia, stroke, or 30‐day readmission between the matched groups. On regression analysis, sex was not an independent risk factor for in‐hospital mortality. Female sex was, however, significantly associated with a decreased odds of 30‐day readmission (odds ratio, 0.90 [95% CI, 0.87–0.92]; P <0.001). Conclusions: Women are more likely to undergo TEVAR for aneurysms, while men are more likely to undergo TEVAR for type B aortic dissection. In‐hospital mortality after TEVAR is comparable among men and women irrespective of indication. Female sex is independently associated with a reduced odds of 30‐day readmission after TEVAR.

11 January 2024 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
TOTakuya Ogami
Takuya Ogami
KDKeith A. Dufendach
Keith A. Dufendach
MIMahnoor Imran
Mahnoor Imran
FTFloyd W. Thoma
Floyd W. Thoma
JBJohannes O. Bonatti
Johannes O. Bonatti
DCDanny Chu
Danny Chu

9 March 2023 in The American Journal of Cardiology
Verified
Journal Article
Closed access
TOTakuya Ogami
Takuya Ogami
DKDustin E Kliner
Dustin E Kliner
CTCatalin Toma
Catalin Toma
SSSaurabh Sanon
Saurabh Sanon
ASAnson J. Conrad Smith
Anson J. Conrad Smith
ISIbrahim Sultan
Ibrahim Sultan

29 June 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
TOTakuya Ogami
Takuya Ogami
EAEdgar Aranda-Michel
Edgar Aranda-Michel
YDYancheng Dai
Yancheng Dai
RHReed Holmes
Reed Holmes
ISIbrahim Sultan
Ibrahim Sultan
Background: Acute aortic syndromes may be prone to misdiagnosis by nonreferral aortic centers with less diagnostic experience. We evaluated regional variability in these misdiagnosis trends among patients transferred to different regional quaternary care centers with presumed acute aortic syndromes. Methods and Results: Two institutional aortic center databases were retrospectively reviewed for emergency transfers in patients diagnosed with acute aortic dissection, intramural hematoma, penetrating aortic ulcer, thoracic aortic aneurysm, or aortic pseudoaneurysm between 2008 and 2020. Transferring diagnoses versus actual diagnoses were reviewed using physician notes and radiology reports. Misdiagnoses were confirmed by a board‐certified cardiothoracic surgeon. A total of 3772 inpatient transfers were identified, of which 1762 patients were classified as emergency transfers. The mean age was 64 years (58% male). Patients were transferred from 203 medical centers by ground (51%) or air (49%). Differences in transfer diagnosis and actual diagnosis were identified in 188 (10.7%) patients. Of those, incorrect classification of Type A versus B dissections was identified among 23%, and 30% of patients with a referring diagnosis of an acute aortic dissection did not have one. In addition, 14% transferred for contained/impending rupture did not have signs of rupture. All misdiagnoses were secondary to misinterpretation of imaging, with motion artifacts (n=32, 17%) and postsurgical changes (n=44, 23%) being common sources of diagnostic error. Conclusions: Misdiagnosis of acute aortic syndromes commonly occurred in patients transferred to 2 separate large aortic referral centers. Although diagnostic accuracy may be improving, there are opportunities for improved physician awareness through standardized web‐based imaging education.